Drug intelligence / Profile preview

fentanyl + morphine + paracetamol + tramadol

Development stage
Unknown
Lead developer
Janssen Pharmaceutical
Modality
Small Molecules
Administration
Oral, Intravenous, Intramuscular, Transdermal (for Fentanyl), Subcutaneous (for Some Opioids)
01

Overview

This is a combination drug consisting of four active ingredients—fentanyl, morphine, paracetamol (acetaminophen), and tramadol. All four are analgesics but act via different mechanisms to provide multimodal pain relief. Fentanyl and morphine are potent opioid agonists primarily targeting the μ-opioid receptor to inhibit pain transmission in the central nervous system. Tramadol is a centrally acting synthetic opioid that not only acts as a μ-opioid receptor agonist but also inhibits serotonin and norepinephrine reuptake, contributing additional analgesic effects[1][6]. Paracetamol is an analgesic and antipyretic agent with a mechanism believed to involve inhibition of prostaglandin synthesis in the central nervous system. The combination aims for synergistic pain control by leveraging both opioid and non-opioid pathways.

02

Targets

MOR (Mu opioid receptor)NET (Norepinephrine Transporter)SERT (Sodium-dependent serotonin transporter)

Beyond the preview

Go deeper on fentanyl + morphine + paracetamol + tramadol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fentanyl + morphine + paracetamol + tramadol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call